Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7046)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fischer TD, Wang JH, Vlada A, Kim JS, Behrns KE. Role of autophagy in differential sensitivity of hepatocarcinoma cells to sorafenib. World J Hepatol 2014; 6(10): 752-758 [PMID: 25349646 DOI: 10.4254/wjh.v6.i10.752] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i10/752.htm |
| Number | Citing Articles |
| 1 |
Xinyu Li, Yong Zhou, Yongshuang Li, Liang Yang, Yingbo Ma, Xueqiang Peng, Shuo Yang, Jingang Liu, Hangyu Li. Autophagy: A novel mechanism of chemoresistance in cancers. Biomedicine & Pharmacotherapy 2019; 119: 109415 doi: 10.1016/j.biopha.2019.109415
|
| 2 |
Si-Tu Xue, Ke Li, Yang Gao, Lu-Yao Zhao, Yan Gao, Hong Yi, Jian-Dong Jiang, Zhuo-Rong Li. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target. Autophagy 2020; 16(10): 1823 doi: 10.1080/15548627.2019.1709762
|
| 3 |
Qiang Yu, Jiajun Ding, Shisen Li, Yunlong Li. Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions. Cancer Letters 2024; 590: 216856 doi: 10.1016/j.canlet.2024.216856
|
| 4 |
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, Luisa Rendón-Garlant, Patricia Nefertari Ramírez-Flores, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Ethel Daniela Cabello-Ruiz, Fabiola Castorena-Torres, Mario Bermúdez de León. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(3): 1760 doi: 10.3390/ijms25031760
|
| 5 |
Shuai Liu, Mingwei Gao, Xiaoqing Wang, Sentai Ding, Jiaju Lv, Dexuan Gao, Zhiyang Wang, Zhihong Niu. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism. Oncotarget 2016; 7(48): 79141 doi: 10.18632/oncotarget.13003
|
| 6 |
Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, Hina Bharti, Alo Nag. Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.751271
|
| 7 |
Tingting Shi, Hisakazu Iwama, Koji Fujita, Hideki Kobara, Noriko Nishiyama, Shintaro Fujihara, Yasuhiro Goda, Hirohito Yoneyama, Asahiro Morishita, Joji Tani, Mari Yamada, Mai Nakahara, Kei Takuma, Tsutomu Masaki. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2021; 22(23): 13071 doi: 10.3390/ijms222313071
|
| 8 |
Zhihao Wang, Pengchao Hu, Fang Tang, Conghua Xie. HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells. Medical Oncology 2016; 33(5) doi: 10.1007/s12032-016-0765-5
|
| 9 |
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego, José L. Mauriz. Modulation of Autophagy by Sorafenib: Effects on Treatment Response. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00151
|
| 10 |
Pietro Di Fazio, Petra Waldegger, Samir Jabari, Susanne Lingelbach, Roberta Montalbano, Matthias Ocker, Emily P. Slater, Detlef K. Bartsch, Romana Illig, Daniel Neureiter, Thaddeus T. Wissniowski. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer. Oncotarget 2016; 7(20): 28998 doi: 10.18632/oncotarget.8585
|
| 11 |
Zhi Zeng, Qiliang Lu, Yang Liu, Junjun Zhao, Qian Zhang, Linjun Hu, Zhan Shi, Yifeng Tu, Zunqiang Xiao, Qiuran Xu, Dongsheng Huang. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.641522
|
| 12 |
Jingyi Wu, Jianzuo Yao, Shu Jia, Xiaokun Yao, Jingping Shao, Weijuan Cao, Shuwei Ma, Xiaomin Yao, Hong Li. A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma. Heliyon 2023; 9(9): e19352 doi: 10.1016/j.heliyon.2023.e19352
|
| 13 |
Carlemi Calitz, Jenny Rosenquist, Oliver Degerstedt, Jaafar Khaled, Maria Kopsida, Mårten Fryknäs, Hans Lennernäs, Ayan Samanta, Femke Heindryckx. Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27997-3
|
| 14 |
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai, George G. Chen. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(2): 564 doi: 10.1016/j.bbcan.2017.10.002
|
| 15 |
María A. Rodríguez‐Hernández, Raúl González, Ángel J. de la Rosa, Paloma Gallego, Raquel Ordóñez, Elena Navarro‐Villarán, Laura Contreras, Mario Rodríguez‐Arribas, Javier González‐Gallego, José M. Álamo‐Martínez, Luís M. Marín‐Gómez, José A. Del Campo, José L. Quiles, José M. Fuentes, Jesús de la Cruz, José L. Mauriz, Francisco J. Padillo, Jordi Muntané. Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells. Journal of Cellular Physiology 2019; 234(1): 692 doi: 10.1002/jcp.26855
|
| 16 |
Néstor Prieto‐Domínguez, Raquel Ordóñez, Anna Fernández, Carolina Méndez‐Blanco, Anna Baulies, Carmen Garcia‐Ruiz, José C. Fernández‐Checa, José L. Mauriz, Javier González‐Gallego. Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Journal of Pineal Research 2016; 61(3): 396 doi: 10.1111/jpi.12358
|
| 17 |
Shuo Yang, Minggang Wang, Liang Yang, Yan Li, Yingbo Ma, Xueqiang Peng, Xinyu Li, Bowen Li, Hongyuan Jin, Hangyu Li. <p>MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib</p>. OncoTargets and Therapy 2020; : 3557 doi: 10.2147/OTT.S247655
|
| 18 |
K Ashokachakkaravarthy, Biju Pottakkat. Sorafenib resistance and autophagy in hepatocellular carcinoma: A concealed threat. Journal of Cancer Research and Practice 2019; 6(3): 107 doi: 10.4103/JCRP.JCRP_6_19
|
| 19 |
Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, F. P. Reiter, E. N. De Toni, Xuehao Wang. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0187-x
|
| 20 |
Pauline Adjibade, Valérie Grenier St-Sauveur, Miguel Quevillon Huberdeau, Marie-Josée Fournier, Andreanne Savard, Laetitia Coudert, Edouard W. Khandjian, Rachid Mazroui. Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells. Oncotarget 2015; 6(41): 43927 doi: 10.18632/oncotarget.5980
|
| 21 |
TAO HU, PEI LI, ZHONGGUANG LUO, XIAOYU CHEN, JINGYANG ZHANG, CHUNYAO WANG, PING CHEN, ZIMING DONG. Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo. Oncology Reports 2016; 35(1): 43 doi: 10.3892/or.2015.4380
|
| 22 |
Yi Heqing, Long Bin, Ye Xuemei, Li Linfa. The role and mechanism of autophagy in sorafenib targeted cancer therapy. Critical Reviews in Oncology/Hematology 2016; 100: 137 doi: 10.1016/j.critrevonc.2016.02.006
|
| 23 |
Subhadip Mukhopadhyay, Niharika Sinha, Durgesh Nandini Das, Prashanta Kumar Panda, Prajna Paramita Naik, Sujit Kumar Bhutia. Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects. Critical Reviews in Clinical Laboratory Sciences 2016; 53(4): 228 doi: 10.3109/10408363.2015.1135103
|
| 24 |
Barbora Smolková, Tara MacCulloch, Tyler F. Rockwood, Minghui Liu, Skylar J. W. Henry, Adam Frtús, Mariia Uzhytchak, Mariia Lunova, Martin Hof, Piotr Jurkiewicz, Alexandr Dejneka, Nicholas Stephanopoulos, Oleg Lunov. Protein Corona Inhibits Endosomal Escape of Functionalized DNA Nanostructures in Living Cells. ACS Applied Materials & Interfaces 2021; 13(39): 46375 doi: 10.1021/acsami.1c14401
|
| 25 |
Yingqi Huang, Wei Liang, Kun Li, Xialin Liao, Jiawen Chen, Xiusheng Qiu, Kunpeng Liu, Dongbo Qiu, Yunfei Qin. Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling. Biochemical and Biophysical Research Communications 2022; 623: 181 doi: 10.1016/j.bbrc.2022.07.028
|
| 26 |
Esra TOKAY. Determination of Cytotoxic effect and Expression analyses of Apoptotic and Autophagic related genes in Thymoquinone-treated Colon Cancer Cells. Sakarya University Journal of Science 2020; 24(1): 189 doi: 10.16984/saufenbilder.585012
|
| 27 |
Jae-Sung Kim, William C. Chapman, Yiing Lin. Mitochondrial Autophagy in Ischemic Aged Livers. Cells 2022; 11(24): 4083 doi: 10.3390/cells11244083
|
| 28 |
Fabio Ciccarone, Serena Castelli, Maria Rosa Ciriolo. Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/6050123
|
| 29 |
Zi-Xuan Wang, Hong-Wei Chu, Kai-Guang Yang, Bao-Feng Zhao, Zhen Liang, Li-Hua Zhang, Yu-Kui Zhang. Label-Free Quantitative Proteomics Analysis of the Sorafenib Resistance in HepG2 Cells. Journal of Analysis and Testing 2022; 6(3): 308 doi: 10.1007/s41664-021-00176-x
|